|
SEC22B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.98830000136741E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.04470000054036E-07 |
| Normal-vs-Stage2 |
2.648300E-02 |
| Normal-vs-Stage3 |
5.59209999999588E-05 |
| Normal-vs-Stage4 |
1.211240E-04 |
| Stage1-vs-Stage2 |
5.013400E-01 |
| Stage1-vs-Stage3 |
8.650600E-01 |
| Stage1-vs-Stage4 |
7.803800E-01 |
| Stage2-vs-Stage3 |
4.760200E-01 |
| Stage2-vs-Stage4 |
4.412400E-01 |
| Stage3-vs-Stage4 |
9.203000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32439999972678E-07 |
| Normal-vs-AfricanAmerican |
1.3389001018993E-10 |
| Normal-vs-Asian |
1.198150E-01 |
| Caucasian-vs-AfricanAmerican |
7.612300E-04 |
| Caucasian-vs-Asian |
8.427600E-01 |
| AfricanAmerican-vs-Asian |
1.257030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65089999951229E-08 |
| Normal-vs-Female |
2.11379999999206E-05 |
| Male-vs-Female |
1.941820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.215100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.54019999999422E-05 |
| Normal-vs-Age(61-80Yrs) |
8.81370000316295E-08 |
| Normal-vs-Age(81-100Yrs) |
1.940060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.113600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.244600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.311600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.149000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.399400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.582200E-03 |
| Normal-vs-Grade 2 |
2.20949999999442E-05 |
| Normal-vs-Grade 3 |
9.67219999647995E-08 |
| Normal-vs-Grade 4 |
1.950290E-04 |
| Grade 1-vs-Grade 2 |
5.914600E-01 |
| Grade 1-vs-Grade 3 |
8.099600E-01 |
| Grade 1-vs-Grade 4 |
9.250600E-01 |
| Grade 2-vs-Grade 3 |
1.853410E-01 |
| Grade 2-vs-Grade 4 |
4.291000E-01 |
| Grade 3-vs-Grade 4 |
8.745000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.355000E-04 |
| Normal-vs-ccB subtype |
1.7172299999979E-05 |
| ccA subtype-vs-ccB subtype |
1.380170E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.55470000000091E-05 |
| Normal-vs-N1 |
3.043800E-02 |
| N0-vs-N1 |
3.911600E-01 |
|
|
